New Key Statistics Module, Z-Score and F-Score
NAS:PTGX Key Ratios
| Market Cap $ M | 1,530.00 |
| Enterprise Value $ M | 1,189.52 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 14.25 |
| Price/Book | 4.47 |
| Price/Sales | 26.27 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 60.00 |
| EPS (TTM) $ | -1.49 |
| Beneish M-Score | 78.71 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 1.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -12.70 |
| EV-to-EBITDA | -13.17 |
| PEG | -- |
| Shares Outstanding M | 58.64 |
| Net Margin (%) | -131.59 |
| Operating Margin % | -156.09 |
| Pre-tax Margin (%) | -131.59 |
| Quick Ratio | 16.71 |
| Current Ratio | 16.71 |
| ROA % (ttm) | -26.38 |
| ROE % (ttm) | -28.93 |
| ROIC % (ttm) | -890.03 |
| Dividend Yield % | -- |
| Altman Z-Score | 41.30 |
PTGX Number of Guru Trades
PTGX Volume of Guru Trades
Gurus Latest Trades with NAS:PTGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PTGX is held by these investors
Total 1
Protagonist Therapeutics Inc Insider Transactions
No Available Data
News about NAS:PTGX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers